Aprepitant in the Management of Biological Therapies-related Severe Pruritus (AprepIt)

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Daniele Santini, Campus Bio-Medico University

ClinicalTrials.gov Identifier:

NCT01683552

First received: September 5, 2012

Last updated: September 11, 2012

Last verified: September 2012

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	November 2011
Primary Completion Date:	November 2011 (Final data collection date for primary outcome measure)

No publications provided by Campus Bio-Medico University

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Santini D, Vincenzi B, Guida FM, Imperatori M, Schiavon G, Venditti O, Frezza AM, Berti P, Tonini G. Aprepitant for management of severe pruritus related to biological cancer treatments: a pilot study. Lancet Oncol. 2012 Oct;13(10):1020-4. doi: 10.1016/S1470-2045(12)70373-X. Epub 2012 Sep 18.

To Top